KS SB236 | 2023-2024 | Regular Session
Status
Completed Legislative Action
Spectrum: Committee Bill
Status: Failed on April 30 2024 - 100% progression
Action: 2024-04-30 - Senate Died in Committee
Text: Latest bill text (Introduced) [PDF]
Spectrum: Committee Bill
Status: Failed on April 30 2024 - 100% progression
Action: 2024-04-30 - Senate Died in Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requiring drug manufacturers to provide pricing under the federal 340B drug pricing program to pharmacies that enter into contractual agreements with entities covered under the 340B program and prohibiting pharmacy benefits managers from denying patients the freedom to use the pharmacy and healthcare provider of such patient's choice.
Title
Requiring drug manufacturers to provide pricing under the federal 340B drug pricing program to pharmacies that enter into contractual agreements with entities covered under the 340B program and prohibiting pharmacy benefits managers from denying patients the freedom to use the pharmacy and healthcare provider of such patient's choice.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2024-04-30 | Senate | Senate Died in Committee |
| 2023-02-13 | Senate | Senate Referred to Committee on Financial Institutions and Insurance |
| 2023-02-10 | Senate | Senate Introduced |
